For decades, the public health warnings surrounding high-salt diets have focused primarily on the cardiovascular system. Excessive sodium consumption is a well-established driver of hypertension, placing immense strain on the heart and blood vessels and raising the risk of stroke and heart disease. However, a growing body of scientific literature suggests that the damage wrought by a heavy salt intake extends far beyond blood pressure, reaching deep into the central nervous system to interfere with memory, complex thinking, and emotional well-being.
Now, a team of researchers in Japan has identified a potential countermeasure in LPC70, a specialized compound derived from soybeans. Building on previous experiments showing that the ingredient could mitigate high blood pressure and cognitive deficits in mice fed a high-salt diet, a newly published study delves deeper into the exact biological mechanisms at play. The findings reveal that LPC70 exerts a sophisticated, targeted influence on crucial chemical signaling pathways in both the kidneys and the brain, offering a fresh perspective on how nutritional interventions might someday protect long-term health against the pressures of modern diets.
The research, led by a collaborative team including Professor Akihiro Mouri, Dr. Hisayoshi Kubota, and Dr. Kazuhiro Kagotani, centers on prostaglandins—signaling molecules synthesized from arachidonic acid, a vital fatty acid. These substances operate much like localized hormones, orchestrating an array of essential physiological functions across different organ systems.
In the cardiovascular network, prostaglandins help modulate blood pressure by carefully balancing the constriction and dilation of blood vessels. Their role within the brain, however, is substantially more intricate. Depending on the specific cellular receptors they engage, these molecules can trigger signaling cascades that either protect delicate nerve cells from harm or accelerate destructive inflammatory processes, ultimately swaying cognitive faculties, memory retention, and emotional regulation.
LPC70 is a distinct form of soy lysolecithin characterized by a high concentration of lysophosphatidylcholine, where LPC accounts for over 70 percent of the total phospholipids. Although prior trials demonstrated that the compound could ease salt-induced hypertension and cognitive impairments, the underlying physiological processes remained poorly understood, particularly concerning how the substance might alter prostaglandin pathways. To uncover these secrets, Prof. Mouri and Dr. Kubota teamed up with Dr. Kagotani—who is affiliated with Tsuji Oil Mills Co., Ltd., and the Tsuji Health and Beauty Science Laboratory at Mie University—to track the molecular trajectory of mice subjected to a high-salt diet.
Dr. Kubota, serving as the study’s first author, spearheaded the experimental phase. He meticulously evaluated shifts in blood pressure, tracked behavioral modifications, and quantified molecular activity tied to prostaglandins. His meticulous evaluations helped clarify how LPC70 interacts differently with the distinct organs responsible for salt-linked cardiovascular and cognitive decline.
Prof. Mouri and Dr. Kubota conduct their academic work within the Department of Regulatory Science for Evaluation and Development of Pharmaceuticals & Devices at Fujita Health University Graduate School of Medical Science, alongside their appointments at the university’s International Center for Brain Science in Japan. Their findings were released online on May 14, 2026, and subsequently published in Volume 197 of Neurochemistry International on July 1, 2026.
"We wanted to understand the role of LPC70 in coordinating changes in PG signaling across organ systems," Prof. Mouri explained. He noted that the project grew out of an ongoing partnership with Tsuji Oil Mills Co., Ltd., a commercial developer specializing in naturally derived food ingredients.
Soy Compound Improves Blood Pressure and Memory in Mice
As anticipated by the researchers, laboratory mice placed on a high-salt diet quickly developed elevated blood pressure, confirming the immediate physical toll of excessive sodium intake. Yet, the detrimental consequences did not stop at the cardiovascular level.
Behavioral evaluations revealed that the animals also experienced a noticeable decline in social interaction. Furthermore, they exhibited significant difficulties in recognizing objects they had encountered previously, pointing directly to impaired recognition memory. Interestingly, general locomotor activity and anxiety-like behaviors remained largely unchanged among the salt-fed subjects. This specific behavioral profile indicates that excessive salt consumption selectively disrupts complex cognitive and social processing rather than inducing generalized neurological impairment.
When the research team supplemented the high-salt diets of another group of mice with LPC70, the trajectory changed markedly. The compound successfully mitigated several of the adverse effects. Blood pressure readings improved toward normal ranges, and the treated mice demonstrated markedly better performance during standard behavioral assays testing social interaction and object recognition memory.
These encouraging macroscopic results drove the investigators to look deeper, examining the molecular landscape inside the kidneys and brains of the test subjects to understand how the compound achieved its protective effects.
Different Protective Effects in the Kidneys and Brain
Within the renal system, a high-salt diet notoriously triggers inflammation and alters fluid regulation. The researchers observed that excess salt significantly increased the expression of two key components involved in prostaglandin signaling within the kidneys: cyclooxygenase-2, commonly known as COX-2, and the PGE2 receptor subtype EP3. Both of these molecular actors are known contributors to the pathogenesis of salt-sensitive hypertension.
When LPC70 was introduced, it actively suppressed these salt-driven increases. This downward adjustment indicates that the soy-derived compound helps correct aberrant signaling in the kidneys, thereby restoring a more balanced regulatory environment capable of maintaining normal blood pressure.
In the prefrontal cortex—a brain region critical for higher-order thinking, memory consolidation, and social navigation—the physiological narrative took a different turn. Excess dietary salt led to a reduction in the expression of the PGD2 receptor DP1, a protein typically responsible for driving protective and anti-inflammatory signaling pathways within neural tissue.
LPC70 stepped in to reverse this deficit, successfully restoring the expression levels of the DP1 receptor. Crucially, the compound left DP2—another prostaglandin receptor associated with potentially neurotoxic and harmful effects—untouched. This selective restoration is a critical discovery because it demonstrates that LPC70 does not act as a blunt instrument that merely amplifies or suppresses all prostaglandin activity indiscriminately. Instead, it selectively champions signaling networks that shield neural tissue from damage, providing a plausible mechanistic explanation for the preserved cognitive and social behaviors observed in the mice.
A Surprising Change in Chemical Signaling
The investigation also yielded an unexpected biochemical twist concerning arachidonic acid, the foundational fatty acid the body utilizes to manufacture prostaglandins.
Mice maintained on an excess-salt diet exhibited lower circulating levels of arachidonic acid. Yet, when these same mice were administered LPC70, the tissue concentrations of specific downstream prostaglandins derived from that fatty acid—including PGE2 and PGD2—actually increased.
This counterintuitive finding implies that LPC70 may optimize the body’s metabolic efficiency, helping cells utilize available pools of arachidonic acid more effectively to synthesize protective signaling molecules even under the hostile physiological conditions imposed by high sodium levels.
When viewed collectively, the study’s data reveal a coordinated yet highly nuanced biological response. In the kidneys, LPC70 works to suppress signaling pathways that propel hypertension. In the brain, it steps up to restore protective mechanisms geared toward combating inflammation and cellular injury. The efficacy of the compound, therefore, hinges dynamically on both the specific organ involved and the precise prostaglandin receptors being modulated.
Could Soy-Based Ingredients Help Protect Against Excess Salt?
While these experimental results are encouraging, researchers emphasize a note of caution. The current findings are derived entirely from animal models, meaning that extensive clinical trials involving human participants will be required to verify whether these same physiological benefits translate to people navigating modern diets.
If validated through human research, compounds like LPC70 could eventually pave the way for functional food ingredients designed to mitigate the long-term health hazards associated with high sodium intake. By offering targeted support for both cardiovascular and cognitive health, such nutritional innovations could become valuable tools in promoting healthier aging globally, particularly for populations struggling to reduce dietary salt.
"Our study elucidates LPC70’s role in PG signaling, laying the groundwork for future clinical research and dietary interventions aimed at reducing hypertension-related cognitive decline and promoting healthy aging globally," Prof. Mouri concluded.
The study received financial backing from several institutions, including Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science under project numbers 20K07931, 22K07606, 22K11891, and 23H02843. Additional support was provided by the Fujita Mind-Brain Research & Innovation Center for Drug Generation through Japan’s Peak Research Universities Program under grant JPJS00420240019, alongside the Japan Science and Technology Agency FOREST Program under grant JPMJFR215H.
Further funding and logistical assistance were supplied by Tsuji Oil Mills Co., Ltd., the Education and Research Facility of Animal Models for Human Diseases at Fujita Health University, the Smoking Research Foundation, and the Takeda Science Foundation.
